Moderna combo flu–COVID vaccine: EU guide

If you live in Europe, you can now get a single Moderna mRNA shot that covers both seasonal influenza and COVID-19. For most adults who already plan to vaccinate against both illnesses each autumn, the combined option is a convenient way to stay up to date with one appointment and one needle.

If you’re in the United States, you can’t get this combo yet. Moderna withdrew its previous FDA filing, so for the upcoming season you’ll need separate flu and COVID doses if you want protection against both. Below, we break down who benefits most from the European combined vaccine, how it compares to two separate injections, what the safety and effectiveness evidence says so far, and practical next steps.

What changed and why it matters

Europe is first to authorize Moderna’s combined mRNA vaccine against influenza and COVID-19. National rollouts will vary by country, but pharmacies and general practitioners in the EU/EEA and the UK are expected to be the main access points as supply ramps.
The shot is designed to replace two separate autumn appointments for most adults: your seasonal flu jab and your updated COVID booster.
Trials showed the combo met key immune-response goals compared with licensed flu and COVID vaccines given separately, with side effects in the familiar range for mRNA shots. Regulators judged the benefits to outweigh risks for adults.
Why it matters: One visit and one syringe can improve uptake. Many people who intend to get both shots never get around to booking two appointments; removing that friction can translate into fewer hospitalizations, especially among older adults and those with chronic conditions.

Quick take: Is the combo right for you?

Consider the combined shot if:

You typically receive both a flu vaccine and a COVID booster each autumn.
You prefer one appointment and expect only the usual short-lived side effects.
You’re 50+, have chronic conditions, are a healthcare worker, or live with or care for vulnerable people.

Stick with separate shots if:

Your country’s guidance prioritizes a particular flu or COVID brand for your risk group (for example, high-dose or adjuvanted flu vaccines for the oldest adults). The combo may not replace those in every case.
You had significant side effects after prior mRNA doses and prefer to space vaccinations out to manage downtime.
You’re pregnant or immunocompromised and your clinician recommends a tailored schedule.

How the combo compares to two separate shots

What’s the real-world difference between a combined shot and co-administering two separate vaccines at the same visit?

Appointments and needles: Combo means one booking, one syringe. Co-administration still means two injections, usually in different arms.
Immunogenicity: In Phase 3 studies, the combo matched or exceeded immune responses seen with licensed comparators for both flu and COVID. That’s what regulators require. There’s no sign you “lose” protection by combining.
Side effects: Expect the typical mRNA profile—sore arm, fatigue, headache, low-grade fever—generally resolving in 1–3 days. Reactogenicity was similar to giving the vaccines separately at the same visit, with some studies showing slightly higher short-term symptoms than flu alone but comparable to COVID boosters.
Logistics: For health systems and workplaces, one SKU and one administration can simplify fall campaigns and cut costs.
Flexibility: Two separate shots let you mix brands or target specific formulations (e.g., high-dose flu) if indicated for your age group. The combo locks in a single manufacturer’s formulation.

What’s inside: a plain-language look

Platform: mRNA packaged in lipid nanoparticles, the same technology as Moderna’s COVID shot. The payloads instruct your cells to produce harmless pieces of influenza hemagglutinin (from the season’s selected strains) and the SARS-CoV-2 spike protein (from the year’s WHO-aligned variant update). Your immune system learns to recognize both.
Update cadence: Like seasonal flu vaccines and updated COVID boosters, expect the combo to be reformulated annually to track circulating strains and variants.
Storage and handling: Cold-chain logistics are similar to other Moderna mRNA products. For consumers, that just means pharmacies and clinics manage it; you don’t.

What the evidence shows (without the jargon)

What regulators looked for:

Flu component: Antibody responses at least as good as licensed seasonal flu vaccines, and superior for key strains when possible.
COVID component: Antibody responses that meet or exceed updated monovalent COVID boosters targeting current variants.
Safety: Side-effect patterns consistent with prior mRNA experience and flu vaccination, with careful review of serious adverse events.

What large trials reported publicly:

The combo met its main immune goals compared with licensed flu and COVID shots given separately. For several influenza A strains, immune responses were higher than a standard egg-based comparator in adults, and the COVID component matched or exceeded responses to Moderna’s updated booster given alone.
Side effects tracked with expectations: soreness, fatigue, headache, transient fever/chills. The frequency of short-term symptoms was broadly similar to receiving a COVID booster with or without a flu shot on the same day. Severe events were uncommon.

What hasn’t been fully answered yet:

How protection holds up across an entire winter in different age groups, especially the very old or those with immune compromise. Regulators rely on immunobridging—linking antibody levels to expected protection—so real-world effectiveness data will continue to accumulate post-launch.
Comparative performance versus high-dose or adjuvanted flu vaccines in people 65+. Some countries may still prefer those specialized flu formulations for the oldest adults.

Who should consider the combo first

Adults 50+ and those with chronic conditions like heart or lung disease, diabetes, kidney disease, or obesity. They face higher hospitalization risk from both flu and COVID.
Healthcare, social care, and essential workers who want to minimize downtime and exposure risk.
Caregivers and household contacts of vulnerable people, including infants and the elderly.
Adults who historically put off one of the two shots due to inconvenience.

Who may need individualized advice:

Adults 65+: Your country may recommend high-dose or adjuvanted flu vaccines. Ask whether the combo is advised for your age group this season or if a specialized flu shot plus a separate COVID booster is better.
Pregnant people: Many countries recommend flu and COVID vaccination in pregnancy, but schedules and product choices vary; consult your obstetric clinician.
Immunocompromised individuals: You may need additional or differently timed COVID doses; your clinician can customize the plan.
People with prior myocarditis or strong reactions to mRNA vaccines: Discuss risks and alternatives.

Timing your dose: simple planning for autumn

Aim for early-to-mid autumn, before flu and COVID activity accelerates where you live. One appointment covers both.
If supply is tight, consider booking as soon as local programs open. Pharmacies may allocate limited early stock.
Traveling between hemispheres? If you’ll spend most of the winter in Europe, vaccinate there following local guidance. If you’re returning to the US for winter, you’ll need to plan for separate shots stateside.

Safety profile and what to expect after the jab

Common, short-lived effects (1–3 days):

Soreness, redness, or swelling where injected
Fatigue, headache, muscle aches
Low-grade fever, chills

Less common but important to know:

Short-term swelling of lymph nodes
Rare allergic reactions; stay for the usual observation period after vaccination
Rare myocarditis and pericarditis, seen mostly in young males after mRNA COVID vaccines. Incidence is low; discuss if you’ve had these conditions before.

Practical tips:

Hydrate, plan the shot before a lighter day if you’re sensitive to side effects, and use standard pain relievers if needed (unless advised otherwise by your clinician).

Availability, cost, and access in Europe

Where to get it: Community pharmacies, general practitioners, vaccination centers, and employer clinics as national programs switch on.
Who pays: Coverage varies. Many European countries fund seasonal flu and COVID vaccination for priority groups; private-pay options may exist for others. Expect pricing broadly comparable to getting both shots separately, with payer-negotiated discounts for public programs.
Stock and rollout: Early supply may be limited and prioritized for higher-risk groups. Check your country’s health ministry or pharmacy booking portals for real-time availability.

Why the US doesn’t have it yet (and what to do instead)

Moderna withdrew its previous US application, so the FDA has not authorized the combined shot. For the coming season:

Get a seasonal flu vaccine plus an updated COVID booster. You can receive them at the same visit in different arms, or space them out.
Follow CDC/ACIP guidance for your age and risk factors, especially if you’re 65+ (where high-dose or adjuvanted flu options may be preferred) or immunocompromised.

Pros and cons at a glance

Pros

One appointment, one needle
Immune responses comparable to separate shots
May improve vaccination rates and reduce winter hospitalizations
Streamlined workplace and pharmacy campaigns

Cons

Less flexibility to choose specialized flu formulations (e.g., high-dose) where recommended
Short-term side effects can still occur; some may prefer to split doses across days
Early supply may be limited; access could vary by country and risk group

Alternatives and what’s next in the pipeline

Separate same-day shots: Receive a standard flu vaccine and an updated COVID booster at one visit. Evidence supports co-administration.
Staggered schedule: Flu now, COVID in a few weeks (or vice versa) to spread out side effects or align with local peaks.
Other combos: Additional combination shots (including those from other manufacturers) are in late-stage trials but not yet authorized. Watch for future seasons to bring more options, including potential triple combinations down the line.

Practical decision guide

If you’re an adult in Europe who normally gets both shots: Book the combo when your local program opens.
If you’re 65+ or have special recommendations in your country: Ask your clinician whether a high-dose/adjuvanted flu shot plus a separate COVID booster is preferred for you this season.
If you have a history of strong mRNA side effects or myocarditis: Discuss risks, benefits, and timing; consider spacing vaccines.
If you’re in the US: Plan on separate flu and COVID shots. Co-administration is fine if you want one visit.

Key takeaways

Europe authorized the first combined mRNA vaccine for flu and COVID—a single shot intended to simplify autumn protection.
Trial data show immune responses on par with, or better than, separate shots for key strains, with a familiar side-effect profile.
The combo is a good fit for most adults who already plan to vaccinate for both illnesses; older adults should confirm whether specialized flu formulations remain preferred in their country.
The US does not have this combo yet; Americans should continue with separate seasonal vaccinations.

FAQ

Q: Can I get the combo if I already had a COVID booster this year?
A: Generally you don’t need another COVID dose immediately. The combo is intended to serve as your seasonal update for both flu and COVID. Follow local timing guidance or ask your clinician.

Q: Is the combo stronger than getting two separate shots?
A: It’s designed to be at least as protective. Trials showed comparable or better antibody responses to licensed comparators. Real-world protection will be monitored as rollout expands.

Q: Will I feel worse because it’s two vaccines in one?
A: Most people report side effects similar to those after a COVID booster, sometimes a bit more than flu alone. Symptoms are typically mild and short-lived.

Q: What about RSV—can I take that with the combo?
A: Some countries allow co-administration of RSV with other vaccines, but evidence on triple same-day administration is still accumulating. If you’re eligible for RSV vaccination, ask your clinician about timing.

Q: Is it available for children?
A: The initial authorization is for adults. Pediatric use would require additional studies and regulatory decisions.

Q: I’m traveling between EU countries. Is my vaccine recognized elsewhere?
A: Yes. As with other adult vaccines, your documentation should be valid across the EU/EEA. Keep your digital or paper record handy.

Source & original reading: https://arstechnica.com/health/2026/04/europe-not-us-first-to-authorize-modernas-combo-mrna-flu-covid-vaccine/

Moderna’s combined flu–COVID mRNA shot lands in Europe: should you get it?